BARCELONA, Spain--(BUSINESS WIRE)--Laboratorios Almirall S.A. and Proteros biostructures GmbH announced that they have achieved a scientific milestone in their collaboration –in force since mid 2006- to solve structures of a prominent Almirall drug discovery target in combination with proprietary Almirall compounds triggering commercial payments to Proteros.
